Dr. Robert Bristow, MD of Princess Margaret Cancer Centre discusses molecular markers that have been identified in prognosis and risk of relapse in localized prostate cancer at ASCO GU 2016
Advertisement
[the_ad id="32629"]
Molecular markers that have been identified in prognosis and risk of relapse in localized prostate cancer.
By Editor